Eric Lefkofsky is prominent for being the co-founder as well as the CEO of the famous Tempus. Tempus refers to a technology firm that has established a system of operation meant to aid cancer treatment. It is also worth acknowledging that he is also the Lightbank’s founding partner. Lightbank refers to an investment fund that ventures in troublesome technologies.
In consideration of Groupon (NASDAQ: GRPN), he occupies the position of the Chairman in addition to being the co-founder of the same company. The firm is often referred to as an international e-commerce market. He is also the co-founder of Uptake Technologies which is the best predictive platform of analytics for the largest firms globally. Others include Echo Global Logistics (NASDAQ: ECHO)which refers to a company that deals with technological transportation as well as the outsourcing of logistics. InnerWorkings which relates to an international provider of administered print as well as the remedies that offer promotion, and Mediocean which is the finest alongside the provision of incorporated media technology of procurement.
In the year 2006, Eric Lefkofsky together with Liz, his wife, set up the Lefkofsky Family Foundation. It refers to a private non-profit making platform established with the objective of advancing high-impact projects that facilitate the lives of those living in the societies served. Lefkofsky is currently a Trustee of The Art Institute of Chicago, Lurie Children’s Hospital of Chicago, World Business Chicago, The Museum of Science as well as Industry.
Additionally, Eric Lefkofsky is the Chairperson to the Trustees’ Panel of Steppenwolf Theatre Firm of Chicago. He is an assistant professor at the University of Chicago as well as Accelerated Disruption’s author. Looking into his education, he is a graduate of the University of Michigan. This happened before his attainment of Juris Doctor at the School of Law at the same University.
Being the founder of the great Groupon, Eric Lefkofsky is among the exclusively influential personalities in Chicago. He has given several millions of dollars to facilitate cancer-related research. At the moment, he is the one behind the establishment that aims at taking a smarter strategy towards the cure for cancer.